Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALLENA PHARMACEUTICALS, INC.

(ALNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ALLENA PHARMACEUTICALS, INC.
11/16ALLENA PHARMACEUTICALS : Corporate Presentation November 2021
PU
11/15Allena Pharmaceuticals to Participate in the Stifel 2021 Virtual Healthcare Conference
GL
11/15Allena Pharmaceuticals to Participate in the Stifel 2021 Virtual Healthcare Conference
GL
11/12ALLENA PHARMACEUTICALS : Amendment to Annual Report (Form 10-K/A)
PU
11/10Allena Pharmaceuticals Reports Third Quarter 2021 Financial Results and Recent Corporat..
PU
11/10Allena Pharmaceuticals Reports Third Quarter 2021 Financial Results and Recent Corporat..
AQ
11/10Allena Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Mo..
CI
11/03Allena Pharmaceuticals Receives FDA Fast-Track Designation for Hyperuricemia Treatment ..
MT
11/03Allena Pharmaceuticals Gets Fast Track Designation for Kidney Disease Treatment
DJ
11/03Allena Pharmaceuticals Receives Fast Track Designation from FDA for the Development of ..
AQ
11/03Allena Pharmaceuticals, Inc. Receives Fast Track Designation from FDA for Development o..
CI
09/29ALLENA PHARMACEUTICALS : Doses First Patient in Mid-Stage Trial of Potential Gout Treatmen..
MT
09/29ALLENA PHARMACEUTICALS : Commences Dosing of Gout Patients in Second Phase 2a Trial of ALL..
PU
09/29ALLENA PHARMACEUTICALS : Commences Dosing of Gout Patients in Second Phase 2a Trial of ALL..
AQ
09/29Allena Pharmaceuticals Commences Dosing of Gout Patients in Second Phase 2a Trial of AL..
CI
09/14ALLENA PHARMACEUTICALS : Corporate Presentation September 2021
PU
09/10ALLENA PHARMACEUTICALS : to Participate in H.C. Wainwright's 23rd Annual Global Investment..
AQ
09/09ALLENA PHARMACEUTICALS : to Participate in H.C. Wainwright's 23rd Annual Global Investment..
AQ
08/27ALLENA PHARMACEUTICALS : Delisting/Transfer of Listing (Form 8-K)
PU
08/16ALLENA PHARMACEUTICALS : Wedbush Adjusts Allena Pharmaceuticals' Price Target to $4 From $..
MT
08/11NORTH AMERICAN MORNING BRIEFING : Investors Await -2-
DJ
08/10ALLENA PHARMACEUTICALS : Reports Second Quarter 2021 Financial Results and Recent Corporat..
AQ
08/10Allena Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June..
CI
08/10ALLENA PHARMACEUTICALS : Registered direct offering completed in July with gross proceeds ..
PU
08/03ALLENA PHARMACEUTICALS : to Participate in the 12th Annual Wedbush PacGrow Healthcare Conf..
AQ
08/03ALLENA PHARMACEUTICALS : Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
AQ
07/16ALLENA PHARMACEUTICALS : Announces $28 Million Registered Direct Offering Priced At-the-Ma..
PU
07/14ALLENA PHARMACEUTICALS : Expects to Raise $28 Million in Direct Offering of Common Shares,..
MT
07/13Allena Pharmaceuticals Announces $28 Million Registered Direct Offering Priced At-the-M..
GL
07/13ALLENA PHARMACEUTICALS : ALLN-346 successfully completes Phase 1b safety study; on track t..
PU
07/12ALLENA PHARMACEUTICALS : Corporate Presentation July 2021
PU
07/12ALLENA PHARMACEUTICALS : Provides Update on Clinical Development Programs
AQ
07/12Allena Pharmaceuticals Provides Update on Clinical Development Programs
CI
07/08Allena Pharmaceuticals, Inc. to Present at the Ladenburg Thalmann 2021 Virtual Healthca..
GL
07/07Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GL
06/25ALLENA PHARMACEUTICALS, INC.(NASDAQG : ALNA) dropped from Russell 3000E Value Index
CI
06/25ALLENA PHARMACEUTICALS, INC.(NASDAQG : ALNA) dropped from Russell Microcap Value Index
CI
06/16ALLENA PHARMACEUTICALS : ALLN-346 for the Treatment of Gout in Chronic Kidney Disease
PU
06/08ALLENA PHARMACEUTICALS : Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
AQ
06/08Allena Pharmaceuticals to Host Key Opinion Leader Webinar Focused on ALLN-346 for the T..
GL
06/04ALLENA PHARMACEUTICALS : OF ALLENA PHARMACEUTICALS, INC (Form 8-K)
PU
05/13Allena Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March..
CI
05/12ALLENA PHARMACEUTICALS : Reports First Quarter 2021 Financial Results and Provides Busines..
PU
05/11Allena Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Busine..
GL
05/07ALLENA PHARMACEUTICALS : Files for Up to $200 Million Mixed Shelf
MT
05/04Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GL
04/09ALLENA PHARMACEUTICALS : Reports Inducement Grants Under NASDAQ Listing Rule 5635(4)
AQ
04/08Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GL
04/07ALLENA PHARMACEUTICALS : Appoints Mark J. Fitzpatrick to its Board of Directors
AQ
04/07Allena Pharmaceuticals, Inc. Announces Board Changes
CI
03/09ALLENA PHARMACEUTICALS : Corporate Presentation March 2021
PU
03/09ALLENA PHARMACEUTICALS : Reports Fourth Quarter and Full Year 2020 Financial Results and P..
AQ
03/09Allena Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended Dece..
CI
02/24Allena Pharmaceuticals to Present at Upcoming Investor Conferences in March
GL
02/02Allena Pharmaceuticals, Inc. Announces Executive Changes
CI
02/02Allena Pharmaceuticals Appoints Richard D. Katz, M.D. as Chief Financial Officer
GL
02/02Allena Pharmaceuticals, Inc. Announces Executive Changes
CI
01/04Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January
GL
2020ALLENA PHARMACEUTICALS : Wedbush Adjusts Allena Pharmaceuticals' Price Target to $5 From $..
MT
2020ALLENA PHARMACEUTICALS : Increases Previously Announced Bought Deal to $13 Million
MT
2020Allena Pharmaceuticals Increases Previously Announced Bought Deal to $13.0 Million
GL
2020ALLENA PHARMACEUTICALS : To Raise $10 Million Via Share Sale -- Stock Down 1.5% After-Hour..
MT
2020Allena Pharmaceuticals Announces $10.0 Million Bought Deal Offering
GL
2020ALLENA PHARMACEUTICALS : Announces Appointment of David J. Clark, M.D., M.R.C.P. as Chief ..
AQ
2020Allena Pharmaceuticals, Inc. Announces Executive Changes
CI
2020ALLENA PHARMACEUTICALS : Corporate Presentation December 2020
PU
2020ALLENA PHARMACEUTICALS : Announces Initial Data from Phase 1 Trial of ALLN-346
AQ
2020Allena Pharmaceuticals, Inc. Announces Initial Data from Phase 1 Trial of ALLN-346
CI
2020ALLENA PHARMACEUTICALS : Files Shelf For Up to About 6.1 Million Common Shares on Behalf o..
MT
2020ALLENA PHARMACEUTICALS : to Present Virtually at Evercore ISI 3rd Annual HealthCONx Confer..
AQ
2020ALLENA PHARMACEUTICALS : to Present Virtually at Evercore ISI 3rd Annual HealthCONx Confer..
AQ
2020Allena Pharmaceuticals to Present Virtually at Evercore ISI 3rd Annual HealthCONx Confe..
GL
2020ALLENA PHARMACEUTICALS : Wedbush Adjusts Allena Pharmaceuticals' PT to $6 From $18 on Anti..
MT
2020Allena Pharmaceuticals, Inc. Appoints Geoffrey Swire to Serve as the Acting Chief Opera..
CI
2020ALLENA PHARMACEUTICALS : Corporate Presentation November 2020
PU
1  2  3Next
Upcoming event on ALLENA PHARMACEUTICALS, INC.